Arcus Biosciences EBIT (TTM) Analysis

Arcus Biosciences, Inc. (RCUS)

23.34 -1.22 (-4.97%) USD | NYSE | Jan 15, 11:52

View EBIT (TTM) for RCUS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EBIT (TTM) Chart

Start Trial

View Historical Data

Start Trial

View EBIT Definition

Start Trial

EBIT is an acronym for earnings before interest and taxes.

View EBIT (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EBIT (TTM) Benchmarks

Start Trial

Gilead Sciences, Inc.	Upgrade
Actinium Pharmaceuticals, Inc.	Upgrade
Madrigal Pharmaceuticals, Inc.	Upgrade
Karyopharm Therapeutics, Inc.	Upgrade
Janux Therapeutics, Inc.	Upgrade